Evidence is outlined associating proteolytic events with initiation of lymphocyte blast transformation (LBT) in both antigen-specific and nonspecific mitogen-induced stimulation. It is proposed that lymphocytes normally express the hinge region of the IgG molecule on their surface and that this peptide (pro – thr – cys – pro – pro – pro) approximately constitutes a trigger peptide or detendomer that, by virtue of its proteolytic cleavage, stimulates the cell to LBT and mitosis, the trigger becoming inoperative when NAGA is linked to the threonine. The concept is extended to the malignant cell, which would express a detendomer similar in amino acid sequence and function to the lymphocyte blast detendomer, and would be triggered in a similar way. Evidence for this is presented.

Keywords:
Detendomer, Lymphocyte blast transformation (LBT), Phytohemagglutinin (PHA), ε-Aminocaproic acid (EACA), Antigen-antibody complexes (AAC), Antilymphocyte serum (ALS), γ-Immunoglobulin (IgG), Basic protein of central nervous system myelin (BP), N-Acetylgalactosamin (NAGA), Common tumor antigen (CTA)
This content is only available via PDF.
© 1974 S. Karger AG, Basel
1974
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.